More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$680.19B
EPS
6.58
P/E ratio
30.3
Price to sales
6.43
Dividend yield
1.897%
Beta
0.219933
Previous close
$285.75
Today's open
$288.99
Day's range
$282.33 - $290.25
52 week range
$195.90 - $290.25
show more
CEO
Joaquin Duato
Employees
140800
Headquarters
New Brunswick, NJ
Exchange
New York Stock Exchange
Shares outstanding
2.41B
Issue type
Common Stock
Healthcare
Pharmaceuticals
J&J to Boost Ophthalmology Pipeline With $2.2B Ollin Acquisition
JNJ's $2.2 billion Ollin acquisition adds a phase III eye disease candidate to its pipeline, with Blackstone providing $750 million to fund the development.
Zacks Investment Research • 3 hours ago

J&J to Acquire Ollin Biosciences: A Look at Its Recent Buyouts
J&J's $2.2 billion Ollin Biosciences deal adds a promising retinal disease candidate, building on acquisitions.
Zacks Investment Research • 3 hours ago

Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks Investment Research • 4 hours ago

Wall Street Analysts Think Johnson & Johnson (JNJ) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Zacks Investment Research • 4 hours ago

Louisiana Appeals Court Upholds Millions in Damages in Mesothelioma Case Against Johnson & Johnson
DALLAS--(BUSINESS WIRE)--An appeals court in Louisiana has upheld a multimillion verdict against Johnson & Johnson, in which a jury found that talc in its baby powder caused a New Orlean's woman's mesothelioma and death.In a Nov. 16 ruling, Louisiana's Fourth Circuit Court of Appeal affirmed a trial court's decision to increase damages awarded to the family of Jeannine Henderson. National plaintiffs trial firm Dean Omar Branham Shirley, LLP (DOBS) represented the Henderson family as well as.
Business Wire • 2 hours ago

3 Bulletproof Passive Income Dividend Kings to Buy and Hold Forever
A pending IRS ruling, rising commodity costs, and more test whether the payouts of these passive income Dividend Kings can survive.
24/7 Wall Street • 6 hours ago

Forget SCHD: 4 Dividend Stocks Retirees Should Own Instead
The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) grounds countless retirement portfolios. SCHD screens for durable dividend payers, holds $112.3 billion in net assets and pays a trailing yield near 2.94%.
24/7 Wall Street • 5 hours ago

Johnson & Johnson vs. Pfizer: Consistency vs.
Johnson & Johnson currently exhibits a stronger overall revenue profile than Pfizer by maintaining consistently higher absolute sales volume across every reported period. Over roughly the last eight quarters, Johnson & Johnson achieved steady quarter-over-quarter revenue growth, while Pfizer experienced a volatile quarter-over-quarter trajectory marked by repeating fluctuations.
The Motley Fool • an hour ago

Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs.
Johnson & Johnson currently exhibits a stronger overall position by generating a substantially larger total revenue volume than Novo Nordisk. Johnson & Johnson maintained a consistent quarter-over-quarter upward trajectory, while Novo Nordisk reported mostly flat U.S. dollar figures with the exception of one isolated spike.
The Motley Fool • 8 hours ago

Johnson & Johnson to Buy Ollin Biosciences for $2.2 Billion
Johnson & Johnson has agreed to buy Ollin Biosciences, a clinical-stage biopharmaceutical company developing therapies for serious eye diseases.
WSJ • Nov 16, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Johnson & Johnson commission-free¹. Build wealth for the long term using automated trading and transfers.